1. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 5th edn. American Psychiatric Publishing , Arlington View in Article Crossref

Google Scholar

5. Gooren LJ

Sungkaew T

Giltay EJ

Guadamuz TE Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand. Cult Health Sex. 17 : 92-103 View in Article Scopus (24)

PubMed

Crossref

Google Scholar

10. Hannema SE

Schagen SE

Cohen-Kettenis PT

Delemarre-van de Waal HA The efficacy and safety of pubertal induction using 17beta-estradiol in trans girls. J Clin Endocrinol Metab. 102 : 2356-2363 View in Article PubMed

Google Scholar

11. Vlot MC

Klink DT

den Heijer M

Blankenstein MA

Rotteveel J

Heijboer AC Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone. 95 : 11-19 View in Article Scopus (45)

PubMed

Crossref

Google Scholar

12. Hembree WC

Cohen-Kettenis PT

Gooren L

et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 102 : 3869-3903 View in Article Scopus (373)

PubMed

Crossref

Google Scholar

15. Telfer M

Tollit M

Feldman D Transformation of health-care and legal systems for the transgender population: the need for change in Australia. J Paediatr Child Health. 51 : 1051-1053 View in Article Scopus (21)

PubMed

Crossref

Google Scholar

16. Coleman E

Bockting W

Botzer M

et al. Standards of care for the health of transexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 13 : 165-232 View in Article Scopus (1139)

Crossref

Google Scholar

18. Canner JK

Harfouch O

Kodadek LM

et al. Temporal trends in gender-affirming surgery among transgender patients in the United States. JAMA Surg. 153 : 609-616 View in Article Scopus (50)

PubMed

Crossref

Google Scholar

22. Marinkovic M

Newfield RS Chest reconstructive surgeries in trans masculine youth: experience from one pediatric center. Int J Transgend. 18 : 376-381 View in Article Scopus (10)

Crossref

Google Scholar

23. Olson-Kennedy J

Warus J

Okonta V

Belzer M

Clark LF Chest reconstruction and chest dysphoria in trans masculine minors and young adults: comparisons of nonsurgical and postsurgical cohorts. JAMA Pediatr. 172 : 431-436 View in Article Scopus (20)

PubMed

Crossref

Google Scholar

26. De Vries AL

McGuire JK

Steensma TD

Wagenaar EC

Doreleijers TA

Cohen-Kettenis PT Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 134 : 696-704 View in Article Scopus (288)

PubMed

Crossref

Google Scholar

28. Nakatsuka M Puberty-delaying hormone therapy in adolescents with gender identity disorder. Seishin Shinkeigaku Zasshi. 115 : 316-322 View in Article Google Scholar

32. Chew D

Anderson J

Williams K

May T

Pang K Hormonal treatment in young people with gender dysphoria: a systematic review. Pediatrics. 141 : e20173742 View in Article Scopus (28)

PubMed

Crossref

Google Scholar

33. Delemarre-van de Waal HA

Cohen-Kettenis PT Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol. 155 : S131-S137 View in Article Scopus (151)

PubMed

Crossref

Google Scholar

34. Trotman G

Orta L

Oler L

Casey R

Damle L

Gomez-Lobo V Metabolic profiles in a transgender adolescent population receiving steroid hormone therapy: a pilot study. J Pediatr Adolesc Gynecol. 27 : e38 View in Article Summary

Full Text

Full Text PDF

Google Scholar

35. Klink D

Caris M

Heijboer A

van Trotsenburg M

Rotteveel J Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria. J Clin Endocrinol Metab. 100 : E270-E275 View in Article Scopus (65)

PubMed

Crossref

Google Scholar

36. Tack LJ

Craen M

Dhondt K

Bossche HV

Laridaen J

Cools M Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis. Biol Sex Differ. 7 : 14 View in Article Scopus (25)

PubMed

Crossref

Google Scholar

37. Burke SM

Kreukels BP

Cohen-Kettenis PT

Veltman DJ

Klink DT

Bakker J Male-typical visuospatial functioning in gynephilic girls with gender dysphoria—organizational and activational effects of testosterone. J Psychiatry Neurosci. 1 : 8872147 View in Article Google Scholar

44. Strauss P

Cook A

Winter S

Watson V

Toussaint DW

Lin A Trans pathways: the mental health experiences and care pathways of transgender young people. Summary of results. https://www.telethonkids.org.au/globalassets/media/documents/brain--behaviour/trans-pathwayreport-web2.pdf Date: 2017 Date accessed: November 28, 2018 View in Article Google Scholar

45. van de Grift TC

Elaut E

Cerwenka SC

et al. Effects of medical interventions on gender dysphoria and body image: a follow-up study. Psychosom Med. 79 : 815-823 View in Article Scopus (27)

PubMed

Crossref

Google Scholar

48. Gorin-Lazard A

Baumstarck K

Boyer L

et al. Hormonal therapy is associated with better self-esteem, mood, and quality of life in transexuals. J Nerv Ment Dis. 201 : 996-1000 View in Article Scopus (54)

PubMed

Crossref

Google Scholar

51. Jones BA

Haycraft E

Bouman WP

Brewin N

Claes L

Arcelus J Risk factors for eating disorder psychopathology within the treatment seeking transgender population: the role of cross-sex hormone treatment. Eur Eat Disord Rev. 26 : 120-128 View in Article Scopus (12)

PubMed

Crossref

Google Scholar

52. Mueller SC

Wierckx K

Jackson K

T'Sjoen G Circulating androgens correlate with resting-state MRI in transgender men. Psychoneuroendocrinology. 74 : 91-98 View in Article Scopus (12)

Crossref

Google Scholar

54. Nota NM, Burke SM, den Heijer M, et al. Resting state functional connectivity is affected by testosterone treatment in female-to-male transgender persons. Endocrine Society's 98th Annual Meeting and Expo; Boston, MA; April 1–4, 2016. Poster FRI-141. View in Article Google Scholar

56. Kranz GS

Hahn A

Kaufmann U

et al. Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals. Brain Struct Funct. 223 : 321-328 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

57. Hahn A

Kranz GS

Sladky R

et al. Testosterone affects language areas of the adult human brain. Hum Brain Mapp. 37 : 1738-1748 View in Article Scopus (13)

PubMed

Crossref

Google Scholar

61. Voyer D

Voyer S

Bryden MP Magnitude of sex differences in spatial abilities: a meta-analysis and consideration of critical variables. Psychol Bull. 117 : 250-270 View in Article Scopus (1735)

PubMed

Crossref

Google Scholar

62. Linn MC

Petersen AC Emergence and characterization of sex differences in spatial ability: a meta-analysis. Child Dev. 56 : 1479-1498 View in Article PubMed

Crossref

Google Scholar

63. Asscheman H

Giltay EJ

Megens JA

van Trotsenburg MA

Gooren LJ A long-term follow-up study of mortality in transexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 164 : 635-642 View in Article Scopus (253)

PubMed

Crossref

Google Scholar

64. Stanley K

Cooper J Hormone therapy and venous thromboembolism in a transgender adolescent. J Pediatr Hematol Oncol. 40 : e38-e40 View in Article Google Scholar

67. Aranda Velazquez GB, Mora Porta M, Hanzu FA, Vera J, Ortega E, Halperin I. Effects of sex steroids on cardiovascular risk profile in individuals with gender identity disorder with cross-sex hormone treatment. Endocrine Society's 98th Annual Meeting and Expo; Boston, MA; April 1–4, 2016. Poster PP10–2. View in Article Google Scholar

70. Bachman E

Travison TG

Basaria S

et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 69 : 725-735 View in Article Scopus (141)

PubMed

Crossref

Google Scholar

71. Ferrucci L

Maggio M

Bandinelli S

et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 166 : 1380-1388 View in Article Scopus (172)

PubMed

Crossref

Google Scholar

72. Coviello AD

Kaplan B

Lakshman KM

Chen T

Singh AB

Bhasin S Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 93 : 914-919 View in Article Scopus (198)

PubMed

Crossref

Google Scholar

73. Velho I

Fighera T

Ziegelmann P

Spritzer P Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review. Andrology. 5 : 881-888 View in Article Scopus (27)

PubMed

Crossref

Google Scholar

74. Zuckerman-Levin N

Frolova-Bishara T

Militianu D

Levin M

Aharon-Peretz J

Hochberg Z Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab. 94 : 4820-4827 View in Article Scopus (46)

PubMed

Crossref

Google Scholar

75. Kirkland RT

Keenan BS

Probstfield JL

et al. Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence: correlation with plasma testosterone levels. JAMA. 257 : 502-507 View in Article Scopus (115)

PubMed

Crossref

Google Scholar

76. Chan KJ

Liang JJ

Jolly D

Weinand JD

Safer JD Exogenous testosterone does not induce or exacerbate the metabolic features associated with PCOS among transgender men. Endocr Pract. 24 : 565-572 View in Article Scopus (8)

PubMed

Crossref

Google Scholar

77. Weinand JD

Safer JD Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol. 2 : 55-60 View in Article Scopus (73)

PubMed

Crossref

Google Scholar

80. Getahun D

Nash R

Flanders WD

et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 169 : 205-213 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

81. Van Kesteren PJ

Asscheman H

Megens JA

Gooren LJ Mortality and morbidity in transexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf). 47 : 337-343 View in Article Scopus (319)

PubMed

Crossref

Google Scholar

82. Toorians A

Thomassen M

Zweegman S

et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transexual people. J Clin Endocrinol Metab. 88 : 5723-5729 View in Article Scopus (136)

PubMed

Crossref

Google Scholar

83. Asscheman H

Gooren L

Assies J

Smits J

de Slegte R Prolactin levels and pituitary enlargement in hormone-treated male-to-female transexuals. Clin Endocrinol (Oxf). 28 : 583-588 View in Article Scopus (68)

PubMed

Crossref

Google Scholar

84. Nota N

Dekker M

Klaver M

et al. Prolactin levels during short and long-term cross-sex hormone treatment: an observational study in transgender persons. Andrologia. 49 : e12666 View in Article Scopus (14)

Crossref

Google Scholar

85. Nota N, Klaver M, Dekker M, Heijboer A. Serum prolactin levels in transgender persons before and during cross-sex hormonal treatment. European Congress of Endocrinology; Dublin, Ireland; May 16–20, 2015. Poster EP130. View in Article Google Scholar

86. Defreyne J

Nota N

Pereira C

et al. Transient elevated serum prolactin in transgender women is caused by cyproterone acetate treatment. LGBT Health. 4 : 328-336 View in Article Scopus (16)

PubMed

Crossref

Google Scholar

87. Bisson JR

Chan KJ

Safer JD Prolactin levels do not rise among transgender women treated with estradiol and spironolactone. Endocrine Pract. 24 : 646-651 View in Article Scopus (8)

PubMed

Crossref

Google Scholar

88. Weaver C

Gordon C

Janz K

et al. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 27 : 1281-1386 View in Article Scopus (343)

PubMed

Crossref

Google Scholar

89. Mueller A

Dittrich R

Binder H

et al. High dose estrogen treatment increases bone mineral density in male-to-female transexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. Eur J Endocrinol. 153 : 107-113 View in Article Scopus (40)

PubMed

Crossref

Google Scholar

93. Ainsworth TA

Spiegel JH Quality of life of individuals with and without facial feminization surgery or gender reassignment surgery. Qual Life Res. 19 : 1019-1024 View in Article Scopus (124)

PubMed

Crossref

Google Scholar

95. van de Grift TC

Elaut E

Cerwenka SC

Cohen-Kettenis PT

Kreukels BP Surgical satisfaction, quality of life, and their association after gender-affirming surgery: a follow-up study. J Sex Marital Ther. 44 : 138-148 View in Article Scopus (26)

PubMed

Crossref

Google Scholar